Date Name Title Filing Type Shares Traded Price Total Held
Dec 17, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 6,163 $179.13 1,298,648
Dec 17, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,814 $179.13 1,296,834
Dec 17, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 230,350 $179.13 1,066,484
Dec 17, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 266 -- 10,103
Dec 17, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 10,103 -- --
Dec 14, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 38,391 $179.13 1,294,650
Dec 14, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 -- 245,295
Dec 14, 2012
Director, EVP CSO Pres Regen Res Labs
Director, EVP CSO Pres Regen Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 239,063 -- 239,063
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 3,264 -- 3,264
Dec 14, 2010
Director, EVP CSO & Pres Regn Res Labs
Director, EVP CSO & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 96,736 -- 96,736

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.